Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study

<p>Abstract</p> <p>Background</p> <p>Serum procalcitonin (PCT) is considered useful in predicting the likeliness of developing bacterial infections in emergency setting. In this study, we describe PCT levels overtime and their relationship with bacterial infection in ch...

Full description

Bibliographic Details
Main Authors: Freymuth François, Terzi Nicolas, Ramakers Michel, Vabret Astrid, Fradin Sabine, Parienti Jean-Jacques, Daubin Cédric, Charbonneau Pierre, du Cheyron Damien
Format: Article
Language:English
Published: BMC 2009-09-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/9/157
id doaj-e18be51d06f84dfdb60dd5be5eaaab4d
record_format Article
spelling doaj-e18be51d06f84dfdb60dd5be5eaaab4d2020-11-25T03:48:50ZengBMCBMC Infectious Diseases1471-23342009-09-019115710.1186/1471-2334-9-157Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort studyFreymuth FrançoisTerzi NicolasRamakers MichelVabret AstridFradin SabineParienti Jean-JacquesDaubin CédricCharbonneau Pierredu Cheyron Damien<p>Abstract</p> <p>Background</p> <p>Serum procalcitonin (PCT) is considered useful in predicting the likeliness of developing bacterial infections in emergency setting. In this study, we describe PCT levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease (COPD) critically ill patients with pneumonia.</p> <p>Methods</p> <p>We conducted a prospective cohort study in an ICU of a University Hospital. All consecutive COPD patients admitted for pneumonia between September 2005 and September 2006 were included. Respiratory samples were tested for the presence of bacteria and viruses. Procalcitonin was sequentially assessed and patients classified according to the probability of the presence of a bacterial infection.</p> <p>Results</p> <p>Thirty four patients were included. The PCT levels were assessed in 32/34 patients, median values were: 0.493 μg/L [IQR, 0.131 to 1.471] at the time of admission, 0.724 μg/L [IQR, 0.167 to 2.646] at six hours, and 0.557 μg/L [IQR, 0.123 to 3.4] at 24 hours. The highest PCT (PCTmax) levels were less than 0.1 μg/L in 3/32 (9%) patients and greater than 0.25 μg/L in 22/32 (69%) patients, suggesting low and high probability of bacterial infection, respectively. Fifteen bacteria and five viruses were detected in 15/34 (44%) patients. Bacteria were not detected in patients with PCTmax levels < 0.1 μg/L. In contrast, bacteria were detected in 4/7 (57%) patients estimated unlikely to have a bacterial infection by PCT levels (PCTmax > 0.1 and < 0.25 μg/L).</p> <p>Conclusion</p> <p>Based on these results we suggest that a PCT level cut off > 0.1 μg/L may be more appropriate than 0.25 μg/L (previously proposed for non severe lower respiratory tract infection) to predict the probability of a bacterial infection in severe COPD patients with pneumonia. Further studies testing procalcitonin-based antibiotic strategies are needed in COPD patients with severe pneumonia.</p> http://www.biomedcentral.com/1471-2334/9/157
collection DOAJ
language English
format Article
sources DOAJ
author Freymuth François
Terzi Nicolas
Ramakers Michel
Vabret Astrid
Fradin Sabine
Parienti Jean-Jacques
Daubin Cédric
Charbonneau Pierre
du Cheyron Damien
spellingShingle Freymuth François
Terzi Nicolas
Ramakers Michel
Vabret Astrid
Fradin Sabine
Parienti Jean-Jacques
Daubin Cédric
Charbonneau Pierre
du Cheyron Damien
Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
BMC Infectious Diseases
author_facet Freymuth François
Terzi Nicolas
Ramakers Michel
Vabret Astrid
Fradin Sabine
Parienti Jean-Jacques
Daubin Cédric
Charbonneau Pierre
du Cheyron Damien
author_sort Freymuth François
title Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
title_short Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
title_full Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
title_fullStr Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
title_full_unstemmed Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study
title_sort procalcitonin levels and bacterial aetiology among copd patients admitted to the icu with severe pneumonia: a prospective cohort study
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2009-09-01
description <p>Abstract</p> <p>Background</p> <p>Serum procalcitonin (PCT) is considered useful in predicting the likeliness of developing bacterial infections in emergency setting. In this study, we describe PCT levels overtime and their relationship with bacterial infection in chronic obstructive pulmonary disease (COPD) critically ill patients with pneumonia.</p> <p>Methods</p> <p>We conducted a prospective cohort study in an ICU of a University Hospital. All consecutive COPD patients admitted for pneumonia between September 2005 and September 2006 were included. Respiratory samples were tested for the presence of bacteria and viruses. Procalcitonin was sequentially assessed and patients classified according to the probability of the presence of a bacterial infection.</p> <p>Results</p> <p>Thirty four patients were included. The PCT levels were assessed in 32/34 patients, median values were: 0.493 μg/L [IQR, 0.131 to 1.471] at the time of admission, 0.724 μg/L [IQR, 0.167 to 2.646] at six hours, and 0.557 μg/L [IQR, 0.123 to 3.4] at 24 hours. The highest PCT (PCTmax) levels were less than 0.1 μg/L in 3/32 (9%) patients and greater than 0.25 μg/L in 22/32 (69%) patients, suggesting low and high probability of bacterial infection, respectively. Fifteen bacteria and five viruses were detected in 15/34 (44%) patients. Bacteria were not detected in patients with PCTmax levels < 0.1 μg/L. In contrast, bacteria were detected in 4/7 (57%) patients estimated unlikely to have a bacterial infection by PCT levels (PCTmax > 0.1 and < 0.25 μg/L).</p> <p>Conclusion</p> <p>Based on these results we suggest that a PCT level cut off > 0.1 μg/L may be more appropriate than 0.25 μg/L (previously proposed for non severe lower respiratory tract infection) to predict the probability of a bacterial infection in severe COPD patients with pneumonia. Further studies testing procalcitonin-based antibiotic strategies are needed in COPD patients with severe pneumonia.</p>
url http://www.biomedcentral.com/1471-2334/9/157
work_keys_str_mv AT freymuthfrancois procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT terzinicolas procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT ramakersmichel procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT vabretastrid procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT fradinsabine procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT parientijeanjacques procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT daubincedric procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT charbonneaupierre procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
AT ducheyrondamien procalcitoninlevelsandbacterialaetiologyamongcopdpatientsadmittedtotheicuwithseverepneumoniaaprospectivecohortstudy
_version_ 1724496792593104896